Benzyl-1,2,4-triazoles as CB 1 Cannabinoid Receptor Ligands: Preparation and In Vitro Pharmacological Evaluation

  • Hernandez-Folgado L
  • Decara J
  • Rodríguez de Fonseca F
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a previous study, we have identified 3-alkyl-1,5-diaryl-1 H -1,2,4-triazoles to be a novel class of cannabinoid type 1 receptor (CB 1 R) antagonists. In order to expand the number of cannabinoid ligands with a central 1,2,4-triazole scaffold, we have synthesized a novel series of 1-benzyl-1 H -1,2,4-triazoles, and some of them were evaluated by CB 1 R radioligand binding assays. Compound 12a showed the most interesting pharmacological properties, possessing a CB 1 R affinity in the nanomolar range.

Cite

CITATION STYLE

APA

Hernandez-Folgado, L., Decara, J., Rodríguez de Fonseca, F., Goya, P., & Jagerovic, N. (2016). Benzyl-1,2,4-triazoles as CB 1 Cannabinoid Receptor Ligands: Preparation and In Vitro Pharmacological Evaluation. International Journal of Medicinal Chemistry, 2016, 1–9. https://doi.org/10.1155/2016/1257098

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free